| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |